NCT02895789View on ClinicalTrials.gov

Oxidative Capacity and Exercise Tolerance in Ambulatory SMA

CompletedOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

October 31, 2020

Study Completion Date

January 31, 2021

Conditions
Spinal Muscular Atrophy Type 3Mitochondrial Myopathy
Trial Locations (1)

10032

Columbia University Medical Center, New York

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

Muscular Dystrophy Association

OTHER

lead

Columbia University

OTHER

NCT02895789 - Oxidative Capacity and Exercise Tolerance in Ambulatory SMA | Biotech Hunter | Biotech Hunter